BioCentury
ARTICLE | Company News

Ardana, Senetek deal

July 14, 2008 7:00 AM UTC

Senetek ended a 2004 deal that gave Ardana exclusive rights to manufacture, market, sell and distribute Senetek’s Invicorp vasoactive intestinal polypeptide (VIP)/phentolamine injection in Europe to t...